Meridian has confirmed that the SARS-CoV-2 Nucleocapsid antibody pair (Catalog 9547 & 9548) is capable of detecting the conserved nucleoprotein domain of SARS-CoV-2 variants of interest including Omicron (B.1.1.529) in various commercially available COVID-19 rapid antigen tests.
SARS-CoV-2 Nucleocapsid MAb Pair (9547/9548) |
---|
|
To view Meridian’s range of reagent solutions for COVID-19 CLICK HERE